Trial Profile
Effect of Sarpogrelate on Platelet Aggregation in Patients With Cerebral Infarction: Clinical-pharmacological Dose-response Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Apr 2023
Price :
$35
*
At a glance
- Drugs Sarpogrelate (Primary)
- Indications Cerebral infarction
- Focus Therapeutic Use
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 17 Apr 2015 New trial record